Hot Pursuit     04-Jan-24
Biocon Ltd spurts 0.58%, gains for fifth straight session
Biocon Ltd is quoting at Rs 284, up 0.58% on the day as on 12:44 IST on the NSE. The stock is up 9.15% in last one year as compared to a 20.43% gain in NIFTY and a 36.97% gain in the Nifty Pharma.

Biocon Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 284, up 0.58% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.7% on the day, quoting at 21667.15. The Sensex is at 71884.8, up 0.74%. Biocon Ltd has added around 16.82% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 7.63% in last one month and is currently quoting at 17379.8, up 0.51% on the day. The volume in the stock stood at 72.34 lakh shares today, compared to the daily average of 55.77 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 285.6, up 0.37% on the day. Biocon Ltd is up 9.15% in last one year as compared to a 20.43% gain in NIFTY and a 36.97% gain in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending September 23.

Previous News
  Biocon gets US FDA nod for fungal infection drug
 ( Hot Pursuit - 04-Jun-24   11:18 )
  Biocon Ltd spurts 4.01%, rises for fifth straight session
 ( Hot Pursuit - 26-Apr-24   13:00 )
  Biocon consolidated net profit rises 167.80% in the September 2023 quarter
 ( Results - Announcements 10-Nov-23   17:28 )
  Biocon Ltd spurts 0.58%, gains for fifth straight session
 ( Hot Pursuit - 04-Jan-24   13:00 )
  Biocon Ltd up for fifth session
 ( Hot Pursuit - 06-Feb-24   13:00 )
  Biocon Ltd rises for third straight session
 ( Hot Pursuit - 15-Feb-24   13:05 )
  ICICI Bank board to mull fund raising proposal
 ( Hot Pursuit - 20-Apr-24   14:40 )
  Biocon's Bangalore-based API facility gets GMP certificate from EDQM
 ( Hot Pursuit - 23-Dec-22   09:31 )
  Biocon gets nod from SAHPRA for Tacrolimus capsules
 ( Hot Pursuit - 20-Apr-24   15:36 )
  Biocon consolidated net profit declines 66.09% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:42 )
  Biocon Biologics signs distribution agreement with Sandoz
 ( Corporate News - 22-Dec-23   19:57 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top